Ashton Perlroth

My work in Poland, with Neutrino Geology Inc., exposed me to nuclear instrumentation in a reactor environment, where I contributed to flow-based rare-earth detection methods. In this role, I mentored directly under the CSO, Dr. Andrzej Drukier, a pioneer experimental physicist in dark matter and neutrino detection techniques.

At TrueSight AI, a pioneering company based in Xiamen, China, specializing in the development of artificial intelligence image processors for various industries including consumer electronics, internet, and automotive, I had the rewarding opportunity to serve as an intern within the computer vision research team. Leveraging the company's robust image processing network, my role centered around the study and application of advanced machine learning and AI techniques, setting a strong foundation for potential future endeavors in this rapidly evolving landscape.

Further, my experience in Xiamen provided me with the opportunity to work in-person in China, broadening my abilities to contribute to a diverse and highly efficient team towards a tangible goal.

At Stanford’s Byers Eye Institute, I was an integral part of a research team dedicated to advancing ophthalmic treatments and optimizing the economic application of these therapies. My work focused on leveraging data from the IRIS Registry to assess the impact of COVID-19 on vision loss and treatment frequency. My contributions resulted in 5 publications, including 2 as first author, which were presented at national conferences. This research played a key role in improving patient outcomes and bridging critical gaps in delivery during the pandemic.

During my internship at Kodiak Sciences, a clinical-stage biopharmaceutical company specializing in retinal disease treatments, I was an active participant on their digital health team. My role primarily revolved around the development and optimization of a new generation of SLO/OCT retinal scanning machines. I collaborated closely with a diverse group of professionals, contributing to both the technical and safety aspects of the project.

My primary contributions included various device performance enhancements, safety documentation and interaction with patients. Through this role, I was able to directly contribute to the company's mission of transforming retinal disease treatment through innovative technologies

In May of 2020, I was invited to the US Rowing National Team selection camp. I made the premier development team, and was invited to compete at the 2021 CanAmMex regatta.

In 2022, I was selected to the National Team and competed at the Junior World Championships, held in Varese, Italy, placing 10th in the world. As a boat, we rowed the fastest time ever rowed by a junior American quad.